Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Lauren E. Haydu
Based on 61 articles published since 2008
||||
Expertise Level
The expertise of Lauren E. Haydu ranks in the
  • Top 0.12%
  • ... of 107,286 published authors worldwide on Melanoma
  • ... from 2008 through 2019
  • ... based on contributions to 61 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Haydu, Lauren E   ·   Haydu, L E
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2018
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Vanderbilt University Medical Center, Nashville, TN, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Genentech, San Francisco, CA, USA. · University of California Los Angeles Medical Center, Los Angeles, CA, USA. · Bristol-Myers Squibb, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Northwestern University, Chicago, IL, USA. · University Hospital Essen and German Cancer Consortium, Essen, Germany. · Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. · Pubmed 29449192
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
2017
  • Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA. · Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA 90404, USA. · Helen F. Graham Cancer Center at Christiana Care, Newark, DE 19713, USA. · Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107. · Department of Dermatology, University Duisburg-Essen, University Hospital Essen, 45147 Essen, Germany; German Consortium of Translational Cancer Research, Heidelberg, Germany. · Lineberger Cancer Center, University of North Carolina Chapel Hill, NC 27514, USA. · Glaxosmithkline, Collegeville, PA 19426, USA. · Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. · Bayer Pharma AG, Berlin 13353, Germany. · National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA. · Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. Electronic address: · Pubmed 29141225
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
  • Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, United States. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States; Department of Neurosurgery, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. Electronic address: · Pubmed 28916225
  • Lauren E. Haydu, Richard A. Scolyer, Serigne Lo, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, and John F. Thompson: The University of Sydney, Sydney · Richard A. Scolyer, Robyn P.M. Saw, and John F. Thompson, Royal Prince Alfred Hospital, Camperdown · Michael J. Quinn, The University of Wollongong, Wollongong, NSW, Australia · and Lauren E. Haydu, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28375785
  • Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27911979
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA. · Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. · Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Pubmed 28442307
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · INSERM, Genetic Variation and Human Diseases Unit, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Clinical Applications and Support, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · AP-HP, Hôpital Cochin et Université Paris Descartes, Paris, France. · Duke Cancer Institute, Duke University Medical Center and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. · Department of Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Pubmed 27506587
2016
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Lion Biotechnologies, Woodland Hills, CA, 91637, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 770393, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · EMD Serono, Rockland, MA, 02370, USA. · Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 27776519
Probable:    University of Sydney      
2017
  • Lauren E. Haydu, Richard A. Scolyer, Serigne Lo, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, and John F. Thompson: The University of Sydney, Sydney · Richard A. Scolyer, Robyn P.M. Saw, and John F. Thompson, Royal Prince Alfred Hospital, Camperdown · Michael J. Quinn, The University of Wollongong, Wollongong, NSW, Australia · and Lauren E. Haydu, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28375785
2016
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25956574
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Plastic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26561405
2015
  • Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany. · Melanoma Institute Australia, Sydney, NSW, Australia ; The University of Sydney, Sydney Medical School, Sydney, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany ; Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · Surgical Oncology Group, The University of Queensland, School of Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia. · Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Pubmed 26288839
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
2014
  • Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Department of Medicine, Central Clinical School, The University of Sydney, Australia; Department of Radiation Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia. Electronic address: · Regenerative Neuroscience Group, Brain & Mind Research Institute, The University of Sydney, Australia. · Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Department of Medicine, Central Clinical School, The University of Sydney, Australia. · Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Department of Medical Oncology, The Norwegian Radium Hospital, Oslo, Norway. · Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Department of Radiology and Nuclear Medicine, The Norwegian Radium Hospital, Oslo, Norway. · Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Genesis Cancer Care, Mater Hospital, North Sydney, Australia. · Pubmed 24560764
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · School of Mathematics and Statistics and Prince of Wales Clinical School, University of New South Wales, Kensington, NSW, 2052, Australia. · Discipline of Infectious Diseases and Immunology Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. · Discipline of Dermatology, Bosch Institute, Faculty of Medicine, Sydney Medical School, Sydney, NSW, 2006, Australia. · Melanoma Institute Australia, North Sydney, NSW, 2060, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Westmead Institute of Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, 2145, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Pubmed 24435119
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium. · Surgical Oncology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Dermatology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium. · Embryo and Stem Cells, Department of Development and Regeneration, University of Leuven (KU Leuven), Leuven, Belgium. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Discipline of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia. · Pubmed 24390218
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany · Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia · Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney · Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital · Lauren E. Haydu and John F. Thompson, The University of Sydney · John F. Thompson, Mater Hospital, Sydney · Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2010
2014
  • aWestmead Hospital bWestmead Institute for Cancer Research, Westmead cMelanoma Institute Australia dSydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25054915
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Melanoma Institute Australia, Poche Centre, 40 Rocklands Road, North Sydney, NSW, 2060, Australia; Department of Sydney Melanoma Diagnostic Centre, Missenden Road Camperdown, NSW, 2050, Australia; Discipline of Dermatology, The University of Sydney, Sydney, NSW, Australia. · Pubmed 24641247
  • *Melanoma Institute Australia †Sydney Medical School, The University of Sydney, Sydney ‡Nuclear Medicine and Diagnostic Ultrasound, RPAH Medical Centre, Newtown, New South Wales, Australia. · Pubmed 24633018
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • Sydney Medical School, The University of Sydney, Sydney, Australia, · Pubmed 24052314
2013
  • Westmead Millennium Institute, The University of Sydney, Sydney, Australia. · Pubmed 22981500
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
2012
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Royal North Shore Hospital, St. Leonards, Australia. · Pubmed 21833669
2011
  • Sydney Medical School, The University of Sydney, NSW Australia. · Pubmed 21858829
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
Probable:    Mater Hospital      
2016
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25956574
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Plastic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26561405
2015
  • Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany. · Melanoma Institute Australia, Sydney, NSW, Australia ; The University of Sydney, Sydney Medical School, Sydney, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany ; Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · Surgical Oncology Group, The University of Queensland, School of Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia. · Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Pubmed 26288839
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
2014
  • Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Department of Medicine, Central Clinical School, The University of Sydney, Australia; Department of Radiation Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia. Electronic address: · Regenerative Neuroscience Group, Brain & Mind Research Institute, The University of Sydney, Australia. · Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Department of Medicine, Central Clinical School, The University of Sydney, Australia. · Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Department of Medical Oncology, The Norwegian Radium Hospital, Oslo, Norway. · Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Department of Radiology and Nuclear Medicine, The Norwegian Radium Hospital, Oslo, Norway. · Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Genesis Cancer Care, Mater Hospital, North Sydney, Australia. · Pubmed 24560764
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · School of Mathematics and Statistics and Prince of Wales Clinical School, University of New South Wales, Kensington, NSW, 2052, Australia. · Discipline of Infectious Diseases and Immunology Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. · Discipline of Dermatology, Bosch Institute, Faculty of Medicine, Sydney Medical School, Sydney, NSW, 2006, Australia. · Melanoma Institute Australia, North Sydney, NSW, 2060, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Westmead Institute of Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, 2145, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Pubmed 24435119
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium. · Surgical Oncology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Dermatology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium. · Embryo and Stem Cells, Department of Development and Regeneration, University of Leuven (KU Leuven), Leuven, Belgium. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Discipline of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia. · Pubmed 24390218
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany · Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia · Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney · Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital · Lauren E. Haydu and John F. Thompson, The University of Sydney · John F. Thompson, Mater Hospital, Sydney · Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Institut de Cancerologie Gustav Roussy, Villejuif, Paris-Sud, France. Electronic address: · Pubmed 24074765
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2015
  • Melanoma Institute Australia (formerly the Sydney Melanoma Unit), North Sydney, NSW, Australia. · Pubmed 25384702
2014
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 24802907
  • Melanoma Institute Australia, Sydney, New South Wales 2060, Australia; · Pubmed 24489105
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Melanoma Institute Australia, Sydney, Australia. · Pubmed 24981506
  • Melanoma Institute Australia, 40 Rocklands Road, North Sydney, NSW, 2060, Australia. · Pubmed 24912613
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 24748128
  • Melanoma Institute Australia, Poche Centre, 40 Rocklands Road, North Sydney, NSW, 2060, Australia; Department of Sydney Melanoma Diagnostic Centre, Missenden Road Camperdown, NSW, 2050, Australia; Discipline of Dermatology, The University of Sydney, Sydney, NSW, Australia. · Pubmed 24641247
  • *Melanoma Institute Australia †Sydney Medical School, The University of Sydney, Sydney ‡Nuclear Medicine and Diagnostic Ultrasound, RPAH Medical Centre, Newtown, New South Wales, Australia. · Pubmed 24633018
  • Westmead Hospital, Westmead, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 24496868
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • Sydney Medical School, The University of Sydney, Sydney, Australia, · Pubmed 24052314
2013
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Pubmed 23851608
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23426339
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23403819
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Pubmed 23254691
2012
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Pubmed 22644517
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 22526898
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 22156613
2011
  • Sydney Medical School, The University of Sydney, NSW Australia. · Pubmed 21858829
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 61 total) written by Lauren E. Haydu about Melanoma:

  • Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. 2018
  • Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. 2018
  • A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. 2017
  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. 2017
  • Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. 2017
  • Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis. 2017
  • Clinicopathological features and clinical outcomes associated with TP53 and BRAF 2017
  • Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes. 2017
  • Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness. 2017
  • Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center. 2016
Show List of Full Article Records
Google Searches

Learn more about Lauren E. Haydu using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
University of Sydney
Mater Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2018
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Vanderbilt University Medical Center, Nashville, TN, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Genentech, San Francisco, CA, USA. · University of California Los Angeles Medical Center, Los Angeles, CA, USA. · Bristol-Myers Squibb, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Northwestern University, Chicago, IL, USA. · University Hospital Essen and German Cancer Consortium, Essen, Germany. · Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. · Pubmed 29449192
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
2017
  • Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA. · Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA 90404, USA. · Helen F. Graham Cancer Center at Christiana Care, Newark, DE 19713, USA. · Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107. · Department of Dermatology, University Duisburg-Essen, University Hospital Essen, 45147 Essen, Germany; German Consortium of Translational Cancer Research, Heidelberg, Germany. · Lineberger Cancer Center, University of North Carolina Chapel Hill, NC 27514, USA. · Glaxosmithkline, Collegeville, PA 19426, USA. · Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. · Bayer Pharma AG, Berlin 13353, Germany. · National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA. · Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. Electronic address: · Pubmed 29141225
  • Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX. · Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia. · Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL. · Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia. · Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA. · Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA. · Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia. · Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX. · Director General, Gustave Roussy Cancer Institute, Villejuif, France. · Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA. · Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. · Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 29028110
  • Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, United States. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States; Department of Neurosurgery, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. Electronic address: · Pubmed 28916225
  • Lauren E. Haydu, Richard A. Scolyer, Serigne Lo, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, and John F. Thompson: The University of Sydney, Sydney · Richard A. Scolyer, Robyn P.M. Saw, and John F. Thompson, Royal Prince Alfred Hospital, Camperdown · Michael J. Quinn, The University of Wollongong, Wollongong, NSW, Australia · and Lauren E. Haydu, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28375785
  • Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27911979
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA. · Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. · Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Pubmed 28442307
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · INSERM, Genetic Variation and Human Diseases Unit, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Clinical Applications and Support, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · AP-HP, Hôpital Cochin et Université Paris Descartes, Paris, France. · Duke Cancer Institute, Duke University Medical Center and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. · Department of Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: · Pubmed 27506587
2016
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Lion Biotechnologies, Woodland Hills, CA, 91637, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 770393, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · EMD Serono, Rockland, MA, 02370, USA. · Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 27776519
University of Sydney
2017
  • Lauren E. Haydu, Richard A. Scolyer, Serigne Lo, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, and John F. Thompson: The University of Sydney, Sydney · Richard A. Scolyer, Robyn P.M. Saw, and John F. Thompson, Royal Prince Alfred Hospital, Camperdown · Michael J. Quinn, The University of Wollongong, Wollongong, NSW, Australia · and Lauren E. Haydu, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28375785
2016
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25956574
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Plastic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26561405
2015
  • Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany. · Melanoma Institute Australia, Sydney, NSW, Australia ; The University of Sydney, Sydney Medical School, Sydney, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany ; Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · Surgical Oncology Group, The University of Queensland, School of Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia. · Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Pubmed 26288839
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
2014
  • Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Department of Medicine, Central Clinical School, The University of Sydney, Australia; Department of Radiation Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia. Electronic address: · Regenerative Neuroscience Group, Brain & Mind Research Institute, The University of Sydney, Australia. · Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Department of Medicine, Central Clinical School, The University of Sydney, Australia. · Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Department of Medical Oncology, The Norwegian Radium Hospital, Oslo, Norway. · Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Department of Radiology and Nuclear Medicine, The Norwegian Radium Hospital, Oslo, Norway. · Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Genesis Cancer Care, Mater Hospital, North Sydney, Australia. · Pubmed 24560764
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · School of Mathematics and Statistics and Prince of Wales Clinical School, University of New South Wales, Kensington, NSW, 2052, Australia. · Discipline of Infectious Diseases and Immunology Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. · Discipline of Dermatology, Bosch Institute, Faculty of Medicine, Sydney Medical School, Sydney, NSW, 2006, Australia. · Melanoma Institute Australia, North Sydney, NSW, 2060, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Westmead Institute of Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, 2145, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Pubmed 24435119
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium. · Surgical Oncology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Dermatology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium. · Embryo and Stem Cells, Department of Development and Regeneration, University of Leuven (KU Leuven), Leuven, Belgium. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Discipline of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia. · Pubmed 24390218
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany · Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia · Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney · Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital · Lauren E. Haydu and John F. Thompson, The University of Sydney · John F. Thompson, Mater Hospital, Sydney · Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2010
2014
  • aWestmead Hospital bWestmead Institute for Cancer Research, Westmead cMelanoma Institute Australia dSydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25054915
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Melanoma Institute Australia, Poche Centre, 40 Rocklands Road, North Sydney, NSW, 2060, Australia; Department of Sydney Melanoma Diagnostic Centre, Missenden Road Camperdown, NSW, 2050, Australia; Discipline of Dermatology, The University of Sydney, Sydney, NSW, Australia. · Pubmed 24641247
  • *Melanoma Institute Australia †Sydney Medical School, The University of Sydney, Sydney ‡Nuclear Medicine and Diagnostic Ultrasound, RPAH Medical Centre, Newtown, New South Wales, Australia. · Pubmed 24633018
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • Sydney Medical School, The University of Sydney, Sydney, Australia, · Pubmed 24052314
2013
  • Westmead Millennium Institute, The University of Sydney, Sydney, Australia. · Pubmed 22981500
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
2012
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Royal North Shore Hospital, St. Leonards, Australia. · Pubmed 21833669
2011
  • Sydney Medical School, The University of Sydney, NSW Australia. · Pubmed 21858829
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
Mater Hospital
2016
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25956574
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Plastic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 26561405
2015
  • Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia ; Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany. · Melanoma Institute Australia, Sydney, NSW, Australia ; The University of Sydney, Sydney Medical School, Sydney, Australia. · Department of Dermatology, University Medical Center, Tubingen, Germany ; Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · Surgical Oncology Group, The University of Queensland, School of Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia. · Oncogenomics Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD 4029, Australia. · Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia. · School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4059, Australia. · Pubmed 26288839
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
2014
  • Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Department of Medicine, Central Clinical School, The University of Sydney, Australia; Department of Radiation Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia. Electronic address: · Regenerative Neuroscience Group, Brain & Mind Research Institute, The University of Sydney, Australia. · Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Department of Medicine, Central Clinical School, The University of Sydney, Australia. · Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Department of Medical Oncology, The Norwegian Radium Hospital, Oslo, Norway. · Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Department of Radiology and Nuclear Medicine, The Norwegian Radium Hospital, Oslo, Norway. · Melanoma Institute Australia, Poche Centre, North Sydney, Australia; Australia and New Zealand Melanoma Trials Group, North Sydney, Australia; Genesis Cancer Care, Mater Hospital, North Sydney, Australia. · Pubmed 24560764
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · School of Molecular Bioscience, University of Sydney, Sydney, NSW, 2006, Australia. · Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. · School of Mathematics and Statistics and Prince of Wales Clinical School, University of New South Wales, Kensington, NSW, 2052, Australia. · Discipline of Infectious Diseases and Immunology Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia. · Discipline of Dermatology, Bosch Institute, Faculty of Medicine, Sydney Medical School, Sydney, NSW, 2006, Australia. · Melanoma Institute Australia, North Sydney, NSW, 2060, Australia. · Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Westmead Institute of Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW, 2145, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia. · Pubmed 24435119
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium. · Surgical Oncology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Dermatology, Department of Oncology, University of Leuven (KU Leuven), Leuven, Belgium. · Laboratory of Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium. · Embryo and Stem Cells, Department of Development and Regeneration, University of Leuven (KU Leuven), Leuven, Belgium. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Discipline of Surgery, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia [2] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia. · Pubmed 24390218
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany · Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia · Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney · Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital · Lauren E. Haydu and John F. Thompson, The University of Sydney · John F. Thompson, Mater Hospital, Sydney · Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Institut de Cancerologie Gustav Roussy, Villejuif, Paris-Sud, France. Electronic address: · Pubmed 24074765
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2015
  • Melanoma Institute Australia (formerly the Sydney Melanoma Unit), North Sydney, NSW, Australia. · Pubmed 25384702
2014
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 24802907
  • Melanoma Institute Australia, Sydney, New South Wales 2060, Australia; · Pubmed 24489105
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Melanoma Institute Australia, Sydney, Australia. · Pubmed 24981506
  • Melanoma Institute Australia, 40 Rocklands Road, North Sydney, NSW, 2060, Australia. · Pubmed 24912613
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 24748128
  • Melanoma Institute Australia, Poche Centre, 40 Rocklands Road, North Sydney, NSW, 2060, Australia; Department of Sydney Melanoma Diagnostic Centre, Missenden Road Camperdown, NSW, 2050, Australia; Discipline of Dermatology, The University of Sydney, Sydney, NSW, Australia. · Pubmed 24641247
  • *Melanoma Institute Australia †Sydney Medical School, The University of Sydney, Sydney ‡Nuclear Medicine and Diagnostic Ultrasound, RPAH Medical Centre, Newtown, New South Wales, Australia. · Pubmed 24633018
  • Westmead Hospital, Westmead, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 24496868
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • Sydney Medical School, The University of Sydney, Sydney, Australia, · Pubmed 24052314
2013
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Pubmed 23851608
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23426339
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23403819
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Pubmed 23254691
2012
  • Melanoma Institute Australia, North Sydney, NSW, Australia. · Pubmed 22644517
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 22526898
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 22156613
2011
  • Sydney Medical School, The University of Sydney, NSW Australia. · Pubmed 21858829
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
Royal Prince Alfred Hospital
2014
  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. · Melanoma Institute Australia and the University of Sydney, Sydney Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney and Discipline of Pathology, Sydney Medical School, The University of Sydney, Australia. · Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia. · Priority Research Centre for Cancer Research, Oncology and Immunology Unit, University of Newcastle, NSW, Australia. · Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. · Pubmed 25333256
2014
  • *Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands †Melanoma Institute Australia, Sydney, New South Wales, Australia Disciplines of ‡Surgery, and §Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; and ¶Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25072430
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
2013
  • Department of Melanoma & Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 23688975
2012
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22350600
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 21975320
6 Other Locations Show
Yearly article counts 0274524882100
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.